- Home
- DOUG vs VXRT Comparison
DOUG vs VXRT Comparison
Compare DOUG & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- VXRT
- Stock Information
- Founded
- DOUG 1911
- VXRT N/A
- Country
- DOUG United States
- VXRT United States
- Employees
- DOUG N/A
- VXRT N/A
- Industry
- DOUG Building operators
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOUG Real Estate
- VXRT Health Care
- Exchange
- DOUG Nasdaq
- VXRT Nasdaq
- Market Cap
- DOUG 142.0M
- VXRT 119.0M
- IPO Year
- DOUG N/A
- VXRT N/A
- Fundamental
- Price
- DOUG $1.63
- VXRT $0.34
- Analyst Decision
- DOUG
- VXRT Strong Buy
- Analyst Count
- DOUG 0
- VXRT 2
- Target Price
- DOUG N/A
- VXRT $3.00
- AVG Volume (30 Days)
- DOUG 491.6K
- VXRT 2.0M
- Earning Date
- DOUG 05-08-2025
- VXRT 05-12-2025
- Dividend Yield
- DOUG N/A
- VXRT N/A
- EPS Growth
- DOUG N/A
- VXRT N/A
- EPS
- DOUG N/A
- VXRT N/A
- Revenue
- DOUG $995,627,000.00
- VXRT $28,700,000.00
- Revenue This Year
- DOUG $17.61
- VXRT N/A
- Revenue Next Year
- DOUG N/A
- VXRT N/A
- P/E Ratio
- DOUG N/A
- VXRT N/A
- Revenue Growth
- DOUG 4.19
- VXRT 288.94
- 52 Week Low
- DOUG $1.00
- VXRT $0.28
- 52 Week High
- DOUG $2.98
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- DOUG 46.15
- VXRT 35.97
- Support Level
- DOUG $1.58
- VXRT $0.28
- Resistance Level
- DOUG $1.74
- VXRT $0.38
- Average True Range (ATR)
- DOUG 0.12
- VXRT 0.04
- MACD
- DOUG 0.00
- VXRT 0.01
- Stochastic Oscillator
- DOUG 56.36
- VXRT 40.00
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.